Table 1 Demographic and clinical characteristics of the study population (exploratory cohort)
From: ESRD-associated immune phenotype depends on dialysis modality and iron status: clinical implications
PD n = 138 | HD n = 537 | p | |
|---|---|---|---|
Age (years) | 51 ± 15 | 53 ± 13 | 0.093 |
Gender (% male) | 75% | 68% | 0.626 |
Dialysis duration (months) | 33 + 20 | 63 + 123 | 0.168 |
Diabetes (%) | 19% | 20% | 0.775 |
BMI | 25.8 ± 4.9 | 25.8 ± 4.8 | 0.988 |
Pre-transplant CMV exposure | 55% | 54% | 0.822 |
Induction therapy (% of patients having received ATG) | 33% | 36% | 0.567 |
Tacrolimus (%) | 62% | 58% | 0.348 |
MMF (%) | 97% | 97% | 0.960 |
Scheduled stéroids withdrawal (%) | 8% | 9% | 0.720 |